What You Should Know:
- Commure, the fast-growing enterprise AI healthcare technology company, today announced it has secured $200M in growth financing from General Catalyst’s Customer Value Fund (CVF). The funding will be used to meet the surging demand for Commure’s full-stack AI platform, which spans revenue cycle management (RCM), ambient AI clinical documentation and workflows, and practice management solutions.
- The CVF transaction enables Commure to scale its investment in
Read More
Abridge’s AI Assistant Expands to Inpatient Notes and Orders in Epic
What You Should Know:
- Abridge, a generative AI platform for clinical conversations, is expanding its capabilities to support inpatient care settings and to queue up outpatient orders.
- The extension of its platform is part of the Workshop program, through which Epic and Abridge have collaborated to develop new, innovative healthcare technologies that are piloted and refined before wider release.
Abridge Inside for Inpatient: Bringing AI Documentation to the
Read More
Collectly Launches “Billie,” an AI Agent for 24/7 Patient Billing Support
What You Should Know:
- Collectly, the AI-powered platform reshaping patient billing and revenue cycle management (RCM), today announced the launch of Billie—a breakthrough AI agent for patient billing and RCM. Billie is available to patients 24/7 across chat, email, text, and voice, providing real-time answers to complex medical billing questions and simple, one-click payment options.
- The launch comes at a critical time when patients are often overwhelmed by confusing medical
Read More
Vivalink Powers University of Louisville Study on How Urban Green Spaces Impact Human Health
What You Should Know:
- Vivalink, a provider of digital healthcare solutions, is supporting a study conducted by the University of Louisville's Christina Lee Brown Envirome Institute on how urban green spaces influence human health. Researchers are using Vivalink’s Biometrics Data Platform to monitor participants’ real-time physiological responses in natural and urban environments, providing valuable health data that could inform urban planning and public health initiatives.
The
Read More
Tennr Raises $101M to Solve Healthcare’s Patient Referral ‘Black Hole’
What You Should Know:
- Tennr, the company helping providers manage the complex and often chaotic patient referral process secures $101M in Series C funding round led by IVP, with participation from new and existing investors including Andreessen Horowitz, Lightspeed, GV, ICONIQ, Foundation Capital, and Frank Slootman.
- The company, which has more than tripled its revenue since its Series B just two quarters ago, is tackling one of the most persistent operational challenges in
Read More
Drug Shortages Cost Hospitals Nearly $900M Annually in Labor
What You Should Know:
- A new analysis from Vizient® reveals the staggering financial impact of drug shortages on U.S. hospitals, with labor costs for managing these disruptions more than doubling since 2019.
- The survey, "Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions," found that in 2023, hospitals spent roughly 20 million hours managing drug shortages, translating to nearly $900 million annually in labor costs.
The Hidden Costs Go Far Beyond
Read More
PwC: Health Services M&A Remains Durable Despite Headwinds
What You Should Know:
- Health services M&A activity has demonstrated remarkable durability, weathering a complicated macroeconomic and political environment to remain well ahead of pre-COVID levels, according to PwC’s US Deals 2025 Mid-Year Outlook for both Health Services and Pharmaceutical and Life Sciences.
- Through May 15, 2025, the market saw 445 announced transactions, bringing the last-twelve-month (LTM) total to 1,265 deals with a disclosed value of approximately
Read More
European Digital Health Startups Face ‘Existential Risk’ Amid Funding Pullback and ROI Demands, New Report Finds
What You Should Know:
- A new report from Black Book Research reveals significant headwinds facing the European digital health sector, with a survey of 54 early-stage startups highlighting investor pullback, cross-border scalability challenges, and increasing demands from health systems for evidence-based ROI.
- The findings paint a picture of a market in a "precarious holding pattern," where many innovative companies are struggling to survive.
Pandemic-Era Winners Now
Read More
Caris Life Sciences Announces Pricing of Initial Public Offering
What You Should Know:
- Caris Life Sciences® (Caris), an AI TechBio company and pioneer in precision medicine, today announced the pricing of its initial public offering (IPO) of 23,529,412 shares of its common stock at a public offering price of $21.00 per share.
- The shares are expected to begin trading on the Nasdaq Global Select Market on June 18, 2025, under the ticker symbol “CAI.” The offering is expected to close on June 20, 2025, subject to customary closing
Read More
Nabla Raises $70M to Build an “Agentic” AI Assistant for Clinicians
What You Should Know:
- Nabla, one of the most widely adopted AI assistants in clinical care secures $70M in Series C funding led by HV Capital, with Highland Europe joining as a key investor, alongside DST Global, and existing investors Cathay Innovation, and Tony Fadell’s Build Collective. The funding brings Nabla’s total capital raised to $120M.
- The new capital will accelerate product development, fuel growth across Nabla’s technical and go-to-market teams, and support strategic
Read More
